NASDAQ : SCNX
Scienture Holdings, Inc. — Key statistics
Healthcare · Pharmaceutical Retailers · United States
Last price 3.49 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.29M |
| Enterprise Value | 7.79M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.64M |
| Shares Outstanding | 1.64M |
| Shares Change (YoY) | +236.59% |
| Shares Change (QoQ) | -2.50% |
| Owned by Insiders (%) | 22.08% |
| Owned by Institutions (%) | 7.89% |
| Float | 1.28M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.44 |
| Forward PS | 1.47 |
| PB Ratio | 0.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 9.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.04 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.48 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -53.47% |
| Return on Assets (ROA) | -8.93% |
| Return on Invested Capital (ROIC) | -10.94% |
| Return on Capital Employed (ROCE) | -16.20% |
| Weighted Average Cost of Capital (WACC) | 24.00% |
| Revenue Per Employee | $91,257 |
| Profits Per Employee | -$4.22M |
| Employee Count | 9 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.99M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 4.08 |
| 52-Week Price Change | -85.89% |
| 50-Day Moving Average | 6.33 |
| 200-Day Moving Average | 9.19 |
| Relative Strength Index (RSI) | 31.96 |
| Average Volume (20 Days) | 84,773 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 105,863 |
| Short Previous Month | 1.30M |
| Short % of Shares Out | 6.44% |
| Short % of Float | 8.27% |
| Short Ratio (days to cover) | 0.28 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 821,315 |
| Gross Profit | 720,438 |
| Operating Income | -13.72M |
| Pretax Income | -39.95M |
| Net Income | -37.95M |
| EBITDA | -12.36M |
| EBIT | -13.72M |
| Loss Per Share | -$32.46 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 8.19M |
| Total Debt | 10.69M |
| Net Cash | -2.50M |
| Net Cash Per Share | -$1.52 |
| Equity (Book Value) | 64.10M |
| Book Value Per Share | 39.03 |
| Working Capital | 6.18M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -14.44M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.36M |
| Net Borrowing | 4.33M |
| Free Cash Flow | -14.44M |
| FCF Per Share | -$8.79 |
Margins
| Measure | Value |
|---|
| Gross Margin | 87.72% |
| Operating Margin | -1,671.08% |
| Pretax Margin | -4,863.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -236.59% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,007.97% |
| FCF Yield | -273.03% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 333.67% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.29 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |